Valeo Financial Advisors’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Valeo Financial Advisors’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-234	Closed	-$4K	–	1730
2019 Q1	$4K	Hold	234	–	–	﹤0.01%	1266
2018 Q4	$3K	Hold	234	–	–	﹤0.01%	1253
2018 Q3	$2K	Buy	+234	New	+$2.34K	﹤0.01%	1563

Other funds holding OSIR

FGAM

Financial Gravity Asset Management Lakeway, Texas $562M AUM

Valeo Financial Advisors's OSIR Position: Q2 2019 in Review

Valeo Financial Advisors sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 234 shares — an estimated $4K sold.

Valeo Financial Advisors first reported a position in OSIR in Q3 2018 and held it in 3 quarters. The position peaked at $4K in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

Valeo Financial Advisors reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Valeo Financial Advisors sold 234 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $4K.
Valeo Financial Advisors first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2018 and held it in 3 quarters.
Valeo Financial Advisors's Osiris Therapeutics, Inc. Common Stock position peaked at $4K in Q1 2019.
1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Valeo Financial Advisors's 13F filing for Q2 2019, filed 10 Jul 2019.